Digest Réseau Comment ça marche
Réseau
/
Sociétés
St
Non vérifié

Strand Therapeutics

Ce que nous écrivons

BiotechnologieIndustrieOncologieSantéScience

7 communiqués de presse

Voir tous les communiqués de presse
02/12/2025
Strand Therapeutics Appoints Jeb Keiper to Board of Directors
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
05/11/2025
Strand Therapeutics Promotes Prashant Nambiar to Chief Scientific Officer and Appoints Ethan Cash as Senior Vice President, Head of Portfolio Management and Program Development
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
21/08/2025
Strand Therapeutics Appoints Dr. Jason J. Luke as Chief Medical Officer
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
21/08/2025
Strand Therapeutics Appoints Dr. Jason J. Luke as Chief Medical Officer
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
07/08/2025
Oncologie
Santé
Biotechnologie
Médecine - Divers
Science
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
28/05/2025
Science
Biotechnologie
Industrie pharmaceutique
Oncologie
Santé
Médecine - Divers
Industrie
Strand Therapeutics Announces Initial First-in-human Phase 1 Data for STX-001 in Patients with Advanced Solid Tumors at The 2025 ASCO Annual Meeting
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0
28/04/2025
Événements
Industrie
Santé
Biotechnologie
Santé Publique
Science
Potential First-in-Class Data from Preclinical Program for STX-003, a Programmable mRNA Therapy to Treat Solid Tumor Cancers
Source
Strand Therapeutics
Émetteur
Business Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0